Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
From Biden’s ‘war’ on gas prices to ‘small...
US diplomatic facility in Iraq struck by drone
From Biden’s ‘war’ on gas prices to ‘small...
171 million travelers face airport delays as Democrats’...
FDA launches new AI-powered system to track drug...
Cornyn reverses on filibuster stance to push Trump’s...
DAVID MARCUS: Sen Thune has no idea how...
Trump touts 5-0 sweep by endorsed candidates in...
US destroys 16 Iranian mine boats as Strait...
House GOP urges Trump to choke off Iran...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

Oversubscribed Share Purchase Plan Raises $1.5 Million

by admin November 27, 2025
November 27, 2025
Oversubscribed Share Purchase Plan Raises $1.5 Million

Further to its announcement on 20 October 20251, Jindalee Lithium Limited (ASX: JLL, OTCQX: JNDAF) (Company) is pleased to advise the results of its Share Purchase Plan (SPP). The SPP closed for applications on 20 November 2025, and the Company has today completed the allocation and issuance of shares and options under the SPP, raising total proceeds of $1.5 million.

The SPP, which targeted to raise up to $1 Million, was met with strong demand and closed oversubscribed. In accordance with the SPP Offer Booklet2, the Board exercised its discretion to accept oversubscriptions, resulting in total proceeds of $1.5 million. To ensure a fair allocation, applications for amounts greater than $5,000 were scaled back on a pro-rata basis. Excess application monies will be refunded to applicants in line with the SPP terms2.

A total of 2,720,065 fully paid ordinary shares (Shares) were issued at $0.55 per Share. Eligible shareholders also received one (1) option for every one (1) Share allotted, exercisable at $0.825 and expiring 30 November 2028 (Option), for nil upfront consideration. Participants in the placement announced on 20 October 2025 will also receive Options on the same basis as SPP participants, to be issued subject to shareholder approval at the Company’s general meeting to be held on 10 December 2025.

Funds raised will be used to advance the McDermitt Lithium Project, including exploration drilling, metallurgical testwork, and working capital to progress the proposed United States special purpose acquisition company (SPAC) transaction3.

Commenting on the SPP, Ian Rodger, the Company’s Managing Director and CEO, said “We are grateful for the outstanding support from our shareholders. The strong response to the SPP reflects confidence in Jindalee and the strategic importance of the McDermitt Project. On behalf of the Board, we thank you for your continued support.”

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Crypto Market Update: Altcoin Prices Rise as New XRP ETFs Launch
next post
How the White House turkey pardon became an American tradition

You may also like

NATO Defense Spending Pledge Puts Spotlight on Platinum...

August 22, 2025

Crypto Market Recap: Bitcoin Hits Record as Congress...

July 15, 2025

Solar Panel Makers Look to Sub Copper for...

January 16, 2026

Nine Mile Metals

February 3, 2026

Federal Court of Australia Approves Transformational Acquisition of...

September 14, 2024

Perpetua Resources Secures US$255 Million Investment to Advance...

November 10, 2025

Top 5 Canadian Mining Stocks This Week: St....

June 14, 2025

Top 5 US Lithium Stocks (Updated January 2026)

January 9, 2026

Strong Initial Silver-Gold-Manganese Mineralization at Prince Silver Project

January 13, 2026

SAGA Metals Completes Annual Work Program at North...

December 30, 2025

Recent Posts

  • From Biden’s ‘war’ on gas prices to ‘small price to pay’: GOP shifts tone as Iran conflict hits pumps
  • US diplomatic facility in Iraq struck by drone
  • From Biden’s ‘war’ on gas prices to ‘small price to pay,’ GOP shifts tone as Iran conflict hits pumps
  • 171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns
  • FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (981)
    • Investing (4,311)
    • Politics (5,200)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.